Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

被引:8
|
作者
Hackman, Jada [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Patel, Eshan U. [3 ]
Mehta, Shruti H. [2 ]
Kirk, Gregory D. [2 ,4 ]
Astemborski, Jacquie [2 ]
Ray, Stuart C. [4 ]
Thomas, David L. [2 ,4 ]
Laeyendecker, Oliver [1 ,2 ,4 ]
机构
[1] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; 1CE; Phylogenetic; Molecular epidemiology; PWID; Injection drug use; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HCV INFECTION; NEW-YORK; TRANSMISSION; USERS; HIV; PREVALENCE; VANCOUVER; NETWORK;
D O I
10.1016/j.meegid.2019.104078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR= 1.66 [95% CI: 1.12-2.45]), age < 35 years (PR= 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR= 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR= 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
    Woyesa, Shiferaw Bekele
    Amente, Kellemuwa Desalegn
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1061 - 1068
  • [42] History of detention and the risk of hepatitis C among people who inject drugs in Germany
    Gassowski, Martyna
    Nielsen, Stine
    Bannert, Norbert
    Bock, Claus-Thomas
    Bremer, Viviane
    Ross, R. Stefan
    Wenz, Benjamin
    Marcus, Ulrich
    Zimmermann, Ruth
    Hecht, Andreas
    Heinz, Werner
    Klee, Juergen
    Leicht, Astrid
    Scherbaum, Norbert
    Schaeffer, Dirk
    Santos-Hoevener, Claudia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 100 - 106
  • [43] Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada
    Young, Samantha
    Wood, Evan
    Milloy, M. -J.
    DeBeck, Kora
    Dobrer, Sabina
    Nosova, Ekaterina
    Kerr, Thomas
    Hayashi, Kanna
    SUBSTANCE ABUSE, 2018, 39 (04) : 461 - 468
  • [44] PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland
    Sherman, Susan G.
    Schneider, Kristin E.
    Park, Ju Nyeong
    Allen, Sean T.
    Hunt, Derrick
    Chaulk, C. Patrick
    Weir, Brian W.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 195 : 148 - 155
  • [45] Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan
    Ruisenor-Escudero, Horacio
    Wirtz, Andrea L.
    Berry, Mark
    Mfochive-Njindan, Iliassou
    Paikan, Feda
    Yousufi, Hussain A.
    Yadav, Rajpal S.
    Burnham, Gilbert
    Vu, Alexander
    DRUG AND ALCOHOL DEPENDENCE, 2014, 143 : 127 - 133
  • [46] Access to hepatitis C care for people who inject drugs and people in prisons
    Oru, Ena
    Verster, Annette
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (09): : 662 - 663
  • [47] An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of Baltimore
    Gonzalez Corro, Luis A.
    Zook, Katie
    Landry, Miles
    Rosecrans, Amanda
    Harris, Robert
    Gaskin, Darrell
    Falade-Nwulia, Oluwaseun
    Page, Kathleen R.
    Lucas, Gregory M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [48] Hepatitis C reinfection by treatment pathway among people who inject drugs in Tayside, Scotland
    Caven, Madeleine
    Robinson, Emma
    Macpherson, Iain
    Dillon, John
    JOURNAL OF HEPATOLOGY, 2020, 73 : S620 - S621
  • [49] Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs
    Pilon, Richard
    Leonard, Lynne
    Kim, John
    Vallee, Dominic
    De Rubeis, Emily
    Jolly, Ann M.
    Wylie, John
    Pelude, Linda
    Sandstrom, Paul
    PLOS ONE, 2011, 6 (07):
  • [50] HEPATITIS C CARE CONTINUUM AMONG PEOPLE WHO INJECT DRUGS IN KING COUNTY, WA
    Ebersberger, J.
    Tsui, J., I
    Corcorran, M.
    Glick, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 480 - 480